Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mrunal Gosavi"'
Publikováno v:
International Journal of Advanced Research in Science, Communication and Technology. :584-587
Suicide is one of the most serious social health issues that exist in today's culture. We can refer suicidal thoughts to act of killing yourself intentionally. It can be used as a suicide risk measure. India is among the top countries among in the wo
Publikováno v:
Viral immunology. 35(6)
Various vaccines are under development to prevent chikungunya (CHIKV) infection. For the assessment of the CHIKV vaccine-induced antibody response, it is extremely important to understand antibody response after the infection has occurred. Previously
Autor:
Mrunal Gosavi, Harshad P. Patil
Publikováno v:
Vaccine. 40(34)
Currently there is no clinically approved chikungunya virus (CHIKV) vaccine for immunization. Though definite need is felt, long disappearance of CHIKV has been a concern. Inactivated CHIKV (I-CHIKV) is an attractive antigen to develop effective vacc
Autor:
Shubham Shrivastava, Akhilesh Chandra Mishra, Mrunal Gosavi, Anamika Solaskar, Divya Tiraki, Vidya A. Arankalle
Publikováno v:
SN Comprehensive Clinical Medicine. 2:613-618
Dengue is the fastest spreading mosquito-borne viral infection across the globe affecting over 40% of world populations. Co-existence of 4 distinct serotypes, disease severity due to secondary infection, and continuous evolution of dengue viruses ove
Autor:
Akhilesh Chandra Mishra, Meera Modak, Ruta Kulkarni, Dileep Wani, Vidya A. Arankalle, Mrunal Gosavi
Publikováno v:
Indian Journal of Medical Research, Vol 151, Iss 1, Pp 71-78 (2020)
The Indian Journal of Medical Research
The Indian Journal of Medical Research
Background & objectives: Dengue diagnosis is routinely carried out by detection of dengue virus (DENV) antigen NS1 and/or anti-DENV IgM antibodies using enzyme-linked immunosorbent assays (ELISAs) and rapid diagnostic tests (RDTs). This study was aim
Publikováno v:
Am J Trop Med Hyg
Current chikungunya antibody prevalence and titers are likely to differ based on the exposure rates before the 2006 reemergence in India. For vaccine usage, such data are of immense importance. This study addresses age-stratified IgG titers and its s
Autor:
Akhilesh Chandra Mishra, Mrunal Gosavi, Prajakta S. Rane, Harshad P. Patil, Vidya A. Arankalle
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 39(10)
Chikungunya (CHIKV) reemerged in India after a gap of 32 years, in 2005-2006 and has established endemicity in Pune. To assess the degree of CHIKV exposure, we estimated age-stratified prevalence of IgG antibodies to CHIKV in Pune population. This re